Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 273

1.

An 1H NMR study of the cytarabine degradation in clinical conditions to avoid drug waste, decrease therapy costs and improve patient compliance in acute leukemia.

Cerchione C, Martinelli G, Pedatella S, De Nisco M, Pugliese N, Manfra M, Marra N, Ronconi S, De Giorgi U, Altini M, Simonetti G, Di Rorà AGL, Bravaccini S, Catalano L, Dora Iula V, Pagano F, Picardi M, Bolognese A, Pane F, Martinelli V.

Anticancer Drugs. 2019 Oct 15. doi: 10.1097/CAD.0000000000000850. [Epub ahead of print]

PMID:
31633499
2.

Hashimoto Thyroiditis in Primary Thyroid Non-Hodgkin Lymphoma.

Travaglino A, Pace M, Varricchio S, Insabato L, Giordano C, Picardi M, Pane F, Staibano S, Mascolo M.

Am J Clin Pathol. 2019 Oct 4. pii: aqz145. doi: 10.1093/ajcp/aqz145. [Epub ahead of print]

PMID:
31584614
3.

Lung Cryobiopsy for the Diagnosis of Interstitial Lung Diseases: A Series Contribution to a Debated Procedure.

Harari S, Cereda F, Pane F, Cavazza A, Papanikolaou N, Pelosi G, Scarioni M, Uslenghi E, Zompatori M, Caminati A.

Medicina (Kaunas). 2019 Sep 19;55(9). pii: E606. doi: 10.3390/medicina55090606.

4.

Treatment Patterns in Patients with Chronic-Phase Chronic Myeloid Leukaemia in Routine Clinical Practice: the SIMPLICITY Italian Population.

Abruzzese E, Bosi A, Breccia M, D'Adda M, Di Renzo N, Liberati AM, Porrini R, Orlandi EM, Pane F, Pungolino E, Sorà F, Stagno F, Sen GP, Gentilini F, De Solda F, Gambacorti-Passerini C.

Mediterr J Hematol Infect Dis. 2019 May 1;11(1):e2019025. doi: 10.4084/MJHID.2019.025. eCollection 2019.

5.

Efficacy and safety of ruxolitinib and hydroxyurea combination in patients with hyperproliferative myelofibrosis.

Breccia M, Luciano L, Pugliese N, Rossi E, Tiribelli M, Scalzulli E, Bonifacio M, Martino B, Latagliata R, Benevolo G, Caocci G, Binotto G, Martinelli V, Cavo M, Pane F, De Stefano V, Foà R, Palandri F.

Ann Hematol. 2019 Aug;98(8):1933-1936. doi: 10.1007/s00277-019-03727-6. Epub 2019 Jun 14.

PMID:
31201513
6.

Lanthionine and Other Relevant Sulfur Amino Acid Metabolites: Detection of Prospective Uremic Toxins in Serum by Multiple Reaction Monitoring Tandem Mass Spectrometry.

Perna AF, Pane F, Sepe N, Fontanarosa C, Pinto G, Zacchia M, Trepiccione F, Anishchenko E, Ingrosso D, Pucci P, Amoresano A.

Methods Mol Biol. 2019;2007:9-17. doi: 10.1007/978-1-4939-9528-8_2.

PMID:
31148103
7.

Brentuximab vedotin followed by bendamustine supercharge for refractory or relapsed Hodgkin lymphoma.

Picardi M, Della Pepa R, Giordano C, Pugliese N, Mortaruolo C, Trastulli F, Rascato MG, Cappuccio I, Raimondo M, Memoli M, Monteverde M, Mascolo M, Pane F.

Blood Adv. 2019 May 14;3(9):1546-1552. doi: 10.1182/bloodadvances.2019000123.

8.

Infection control in patients treated for chronic lymphocytic leukemia with ibrutinib or idelalisib: recommendations from Italian society of hematology.

Zinzani PL, Rambaldi A, Gaidano G, Girmenia C, Marchetti M, Pane F, Tura S, Barosi G.

Leuk Res. 2019 Jun;81:88-94. doi: 10.1016/j.leukres.2019.04.016. Epub 2019 May 2. Review.

PMID:
31055248
9.

Successful endovascular treatment of a spontaneous bleeding accessory spleen: A case report.

Pane F, Cavaglià E, Silvestre M, Coppola M, Corvino F, Borzelli A, Paladini A, Giurazza F, Corvino A, Zobel DB, Amodio F, Capasso F, Niola R.

Radiol Case Rep. 2019 Apr 12;14(7):787-790. doi: 10.1016/j.radcr.2019.03.037. eCollection 2019 Jul.

10.

Adding hydroxyurea in combination with ruxolitinib improves clinical responses in hyperproliferative forms of myelofibrosis.

Pugliese N, Giordano C, Nappi D, Luciano L, Cerchione C, Annunziata M, Casale B, Crisà E, Villa MR, Pezzullo L, Iovine M, Picardi M, Grimaldi F, Pane F, Martinelli V.

Cancer Med. 2019 Jun;8(6):2802-2809. doi: 10.1002/cam4.2147. Epub 2019 Apr 17.

11.

Successful endovascular treatment of a recurrent giant celiac artery aneurysm.

Borzelli A, Amodio F, Paladini A, de Magistris G, Giurazza F, Silvestre M, Corvino F, Corvino A, Frauenfelder G, Pane F, Coppola M, Zobel DB, Paladini L, Amodeo EM, Cavaglià E, Niola R.

Radiol Case Rep. 2019 Apr 3;14(6):723-728. doi: 10.1016/j.radcr.2019.03.024. eCollection 2019 Jun.

12.

Delivery of selective internal radiation therapy complicated by variant hepatic vascular anatomy.

Paladini A, Vallati GE, Beomonte Zobel D, Paladini L, Annovazzi A, Sciuto R, Cappelli F, Borzelli A, Pane F, Negroni D, Cernigliaro M, Galbiati A, Del Sette B, Spinetta M, Guzzardi G, Carriero A, Pizzi G.

Radiol Case Rep. 2019 Mar 23;14(6):662-672. doi: 10.1016/j.radcr.2019.03.009. eCollection 2019 Jun.

13.

Microfluidic chip technology applied to fine-needle aspiration cytology samples for IGH clonality assessment.

Vigliar E, Pepe F, Migliatico I, Nacchio M, Cesaro S, Della Pepa R, Bellevicine C, Malapelle U, Fassan M, Pane F, Picardi M, Troncone G.

Diagn Cytopathol. 2019 Aug;47(8):749-757. doi: 10.1002/dc.24184. Epub 2019 Apr 5.

PMID:
30953406
14.

Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1.

Pfeifer H, Cazzaniga G, van der Velden VHJ, Cayuela JM, Schäfer B, Spinelli O, Akiki S, Avigad S, Bendit I, Borg K, Cavé H, Elia L, Reshmi SC, Gerrard G, Hayette S, Hermanson M, Juh A, Jurcek T, Chillón MC, Homburg C, Martinelli G, Kairisto V, Lange T, Lion T, Mueller MC, Pane F, Rai L, Damm-Welk C, Sacha T, Schnittger S, Touloumenidou T, Valerhaugen H, Vandenberghe P, Zuna J, Serve H, Herrmann E, Markovic S, Dongen JJMV, Ottmann OG.

Leukemia. 2019 Aug;33(8):1910-1922. doi: 10.1038/s41375-019-0413-0. Epub 2019 Mar 11.

PMID:
30858550
15.

Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice.

Fava C, Rege-Cambrin G, Dogliotti I, Cerrano M, Berchialla P, Dragani M, Rosti G, Castagnetti F, Gugliotta G, Martino B, Gambacorti-Passerini C, Abruzzese E, Elena C, Pregno P, Gozzini A, Capodanno I, Bergamaschi M, Crugnola M, Bocchia M, Galimberti S, Rapezzi D, Iurlo A, Cattaneo D, Latagliata R, Breccia M, Cedrone M, Santoro M, Annunziata M, Levato L, Stagno F, Cavazzini F, Sgherza N, Giai V, Luciano L, Russo S, Musto P, Caocci G, Sorà F, Iuliano F, Lunghi F, Specchia G, Pane F, Ferrero D, Baccarani M, Saglio G.

Haematologica. 2019 Aug;104(8):1589-1596. doi: 10.3324/haematol.2018.205054. Epub 2019 Feb 28.

16.

A Frontline Approach With Peripherally Inserted Versus Centrally Inserted Central Venous Catheters for Remission Induction Chemotherapy Phase of Acute Myeloid Leukemia: A Randomized Comparison.

Picardi M, Della Pepa R, Cerchione C, Pugliese N, Mortaruolo C, Trastulli F, Giordano C, Grimaldi F, Zacheo I, Raimondo M, Chiurazzi F, Pane F.

Clin Lymphoma Myeloma Leuk. 2019 Apr;19(4):e184-e194. doi: 10.1016/j.clml.2018.12.008. Epub 2018 Dec 20.

PMID:
30704933
17.

Eltrombopag for post-transplant cytopenias due to poor graft function.

Marotta S, Marano L, Ricci P, Cacace F, Frieri C, Simeone L, Trastulli F, Vitiello S, Cardano F, Pane F, Risitano AM.

Bone Marrow Transplant. 2019 Aug;54(8):1346-1353. doi: 10.1038/s41409-019-0442-3. Epub 2019 Jan 24.

PMID:
30679824
18.

Encapsulation of the Dinuclear Trithiolato-Bridged Arene Ruthenium Complex Diruthenium-1 in an Apoferritin Nanocage: Structure and Cytotoxicity.

Petruk G, Monti DM, Ferraro G, Pica A, D'Elia L, Pane F, Amoresano A, Furrer J, Kowalski K, Merlino A.

ChemMedChem. 2019 Mar 5;14(5):594-602. doi: 10.1002/cmdc.201800805. Epub 2019 Feb 11.

PMID:
30674089
19.

Pegfilgrastim in primary prophylaxis of febrile neutropenia in elderly patients with hematological malignancies-bendamustine and G-CSF support.

Cerchione C, De Renzo A, Nappi D, Di Perna M, Della Pepa R, Pugliese N, Catalano L, Pane F, Picardi M.

Support Care Cancer. 2019 May;27(5):1587-1588. doi: 10.1007/s00520-019-4651-5. Epub 2019 Jan 23. No abstract available.

PMID:
30671660
20.

Tenofovir vs lamivudine for the prevention of hepatitis B virus reactivation in advanced-stage DLBCL.

Picardi M, Della Pepa R, Giordano C, Zacheo I, Pugliese N, Mortaruolo C, Trastulli F, Giordano A, Lucignano M, Di Perna M, Raimondo M, Salvatore C, Pane F.

Blood. 2019 Jan 31;133(5):498-501. doi: 10.1182/blood-2018-10-878892. Epub 2018 Dec 7. No abstract available.

21.

Preparation, structure, cytotoxicity and mechanism of action of ferritin-Pt(II) terpyridine compound nanocomposites.

Ferraro G, Pica A, Petruk G, Pane F, Amoresano A, Cilibrizzi A, Vilar R, Monti DM, Merlino A.

Nanomedicine (Lond). 2018 Dec;13(23):2995-3007. doi: 10.2217/nnm-2018-0259. Epub 2018 Dec 3.

PMID:
30501559
22.

Response to "Questions arising on phlebotomy in polycythemia vera: prophylactic measures to reduce thromboembolic events require patient-focused decisions" by Heidel et al.

Barosi G, Passamonti F, Accorsi P, Pane F, Vannucchi AM, Velati C, Gale RP, Tura S, Barbui T.

Leukemia. 2018 Dec;32(12):2727-2728. doi: 10.1038/s41375-018-0259-x. Epub 2018 Sep 28. No abstract available.

PMID:
30267006
23.

A hypothesis of sudden body fluid vaporization in the 79 AD victims of Vesuvius.

Petrone P, Pucci P, Vergara A, Amoresano A, Birolo L, Pane F, Sirano F, Niola M, Buccelli C, Graziano V.

PLoS One. 2018 Sep 26;13(9):e0203210. doi: 10.1371/journal.pone.0203210. eCollection 2018.

24.

(1-3)-β-D-Glucan serum increase and small-airway-invasive radiological findings as early signs of pulmonary aspergillosis in high-risk hematologic patients in the posaconazole era: preliminary observations.

Picardi M, Della Pepa R, Giordano C, Pugliese N, Mortaruolo C, Trastulli F, Grimaldi F, Zacheo I, Raimondo M, Sirignano C, Salvatore P, Pane F.

Ann Hematol. 2019 Feb;98(2):527-531. doi: 10.1007/s00277-018-3441-3. Epub 2018 Jul 23. No abstract available.

PMID:
30033485
25.

Reduced regulatory T cells (Treg) in bone marrow preferentially associate with the expansion of cytotoxic T lymphocytes in low risk MDS patients.

Giovazzino A, Leone S, Rubino V, Palatucci AT, Cerciello G, Alfinito F, Pane F, Ruggiero G, Terrazzano G.

Br J Haematol. 2019 Apr;185(2):357-360. doi: 10.1111/bjh.15496. Epub 2018 Jul 16. No abstract available.

PMID:
30010189
26.

Comprehensive haematological control with ruxolitinib in patients with polycythaemia vera resistant to or intolerant of hydroxycarbamide.

Harrison CN, Griesshammer M, Miller C, Masszi T, Passamonti F, Zachee P, Durrant S, Pane F, Guglielmelli P, Verstovsek S, Jones MM, Hunter DS, Sun W, Li J, Khan M, Habr D, Kiladjian JJ.

Br J Haematol. 2018 Jul;182(2):279-284. doi: 10.1111/bjh.14764. Epub 2017 May 17. No abstract available.

PMID:
29984424
27.

Evidence- and consensus-based recommendations for phlebotomy in polycythemia vera.

Barbui T, Passamonti F, Accorsi P, Pane F, Vannucchi AM, Velati C, Gale RP, Tura S, Barosi G.

Leukemia. 2018 Sep;32(9):2077-2081. doi: 10.1038/s41375-018-0199-5. Epub 2018 Jun 28. No abstract available.

PMID:
29955128
28.

Anticancer Drug-Related Nonvalvular Atrial Fibrillation: Challenges in Management and Antithrombotic Strategies.

Tufano A, Galderisi M, Esposito L, Trimarco V, Sorriento D, Gerusalem G, Picardi M, Lancellotti P, Pane F.

Semin Thromb Hemost. 2018 Jun;44(4):388-396. doi: 10.1055/s-0038-1648229. Epub 2018 May 3. Review.

PMID:
29723895
29.

Caged noble metals: Encapsulation of a cytotoxic platinum(II)-gold(I) compound within the ferritin nanocage.

Ferraro G, Petruk G, Maiore L, Pane F, Amoresano A, Cinellu MA, Monti DM, Merlino A.

Int J Biol Macromol. 2018 Aug;115:1116-1121. doi: 10.1016/j.ijbiomac.2018.04.142. Epub 2018 Apr 30.

PMID:
29709536
30.

2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography/computed tomography in primary extranodal lymphomas: treatment response evaluation and prognosis.

Salvatore B, Fonti R, De Renzo A, Pellegrino S, Ferrara IL, Mainolfi CG, Marano L, Selleri C, Pane F, Del Vecchio S, Pace L.

Q J Nucl Med Mol Imaging. 2018 Apr 24. doi: 10.23736/S1824-4785.18.03043-1. [Epub ahead of print]

PMID:
29697219
31.

Safety and comfort of domestic bortezomib injection in real-life experience.

Cerchione C, Nappi D, Pareto AE, Di Perna M, Zacheo I, Picardi M, Pane F, Catalano L.

Support Care Cancer. 2018 Sep;26(9):3111-3116. doi: 10.1007/s00520-018-4155-8. Epub 2018 Mar 24.

PMID:
29574618
32.

Diagnostic-driven antifungal approach in neutropenic patients at high risk for chronic disseminated candidiasis: preliminary observations on the role of 1,3-β-D-glucan antigenemia and multiphasic contrast-enhanced computed tomography.

Della Pepa R, Cerchione C, Pugliese N, Colicchio R, Salvatore P, Sirignano C, Soscia E, Pagano L, Sanguinetti M, Pane F, Picardi M.

Support Care Cancer. 2018 Jun;26(6):1691-1694. doi: 10.1007/s00520-018-4138-9. Epub 2018 Mar 9. No abstract available.

PMID:
29523967
33.

Lenalidomide at the dose of 25 mg every other day in patients affected by multiple myeloma and renal failure: a real-life experience.

Cerchione C, Nappi D, Pareto AE, Romano A, Martinelli V, Picardi M, Pane F, Catalano L.

Anticancer Drugs. 2018 Apr;29(4):371-372. doi: 10.1097/CAD.0000000000000604.

PMID:
29420336
34.

Ferritin nanocages loaded with gold ions induce oxidative stress and apoptosis in MCF-7 human breast cancer cells.

Monti DM, Ferraro G, Petruk G, Maiore L, Pane F, Amoresano A, Cinellu MA, Merlino A.

Dalton Trans. 2017 Nov 14;46(44):15354-15362. doi: 10.1039/c7dt02370g.

PMID:
29072740
35.

Acute immune toxicity during anti-thymocyte globulin: That's CARPA!

Marotta S, Ricci P, Marano L, Beneduce G, Vitagliano O, De Gregorio F, Grimaldi F, Pane F, Risitano AM.

Am J Hematol. 2018 Jan;93(1):E22-E24. doi: 10.1002/ajh.24945. Epub 2017 Nov 3. No abstract available.

36.

Impact of HLA Disparity in Haploidentical Bone Marrow Transplantation Followed by High-Dose Cyclophosphamide.

Raiola AM, Risitano A, Sacchi N, Giannoni L, Signori A, Aquino S, Bregante S, Di Grazia C, Dominietto A, Geroldi S, Ghiso A, Gualandi F, Lamparelli T, Tedone E, Van Lint MT, Varaldo R, Ibatici A, Marani C, Marotta S, Guolo F, Avenoso D, Garbarino L, Pane F, Bacigalupo A, Angelucci E.

Biol Blood Marrow Transplant. 2018 Jan;24(1):119-126. doi: 10.1016/j.bbmt.2017.10.002. Epub 2017 Oct 9.

37.

Ibrutinib as salvage therapy in mantle cell lymphoma with central nervous system involvement in a pretreated unfit patient.

Vitagliano O, Trastulli F, Cacace F, Leone S, Memoli M, Scalia G, Notarangelo M, Mainolfi CG, De Renzo A, Pane F.

Leuk Lymphoma. 2018 Jul;59(7):1734-1737. doi: 10.1080/10428194.2017.1387910. Epub 2017 Oct 11. No abstract available.

PMID:
29019439
38.

Alternate use of thrombopoietin receptor agonists in adult primary immune thrombocytopenia patients: A retrospective collaborative survey from Italian hematology centers.

Cantoni S, Carpenedo M, Mazzucconi MG, De Stefano V, Carrai V, Ruggeri M, Specchia G, Vianelli N, Pane F, Consoli U, Artoni A, Zaja F, D'adda M, Visentin A, Ferrara F, Barcellini W, Caramazza D, Baldacci E, Rossi E, Ricco A, Ciminello A, Rodeghiero F, Nichelatti M, Cairoli R.

Am J Hematol. 2018 Jan;93(1):58-64. doi: 10.1002/ajh.24935. Epub 2017 Nov 9.

39.

Pleural effusion and molecular response in dasatinib-treated chronic myeloid leukemia patients in a real-life Italian multicenter series.

Iurlo A, Galimberti S, Abruzzese E, Annunziata M, Bonifacio M, Latagliata R, Pregno P, Ferrero D, Sorà F, Orlandi EM, Fava C, Cattaneo D, Bucelli C, Binotto G, Pungolino E, Tiribelli M, Gozzini A, Gugliotta G, Castagnetti F, Stagno F, Rege-Cambrin G, Martino B, Luciano L, Breccia M, Sica S, Bocchia M, Pane F, Saglio G, Rosti G, Specchia G, Cortelezzi A, Baccarani M.

Ann Hematol. 2018 Jan;97(1):95-100. doi: 10.1007/s00277-017-3144-1. Epub 2017 Oct 2.

PMID:
28971265
40.

Chemical and Structural Characterization of Several Mid-Term Explanted Breast Prostheses.

Amoresano A, De Stefano L, Rea I, Pane F, Birolo L, Schonauer F.

Materials (Basel). 2016 Aug 9;9(8). pii: E678. doi: 10.3390/ma9080678.

41.

Clinical pathway for patients with Chronic Myeloid Leukaemia: The Euriclea Project.

Botti S, Gargiulo G, Bombaci F, Artioli G, Cosentino C, Pignatelli AC, Torino D, Lionetti MM, Samarani E, Cappucciati L, Bordiga P, Diodati A, Caffarri C, Rosini I, Pane F.

Acta Biomed. 2017 Jul 18;88(3S):5-12. doi: 10.23750/abm.v88i3 -S.6608.

42.

Rituximab in a risk-adapted treatment strategy gives excellent therapeutic results in nodular lymphocyte-predominant Hodgkin lymphoma.

Della Pepa R, Picardi M, Giordano C, Zacheo I, Pugliese N, Cerchione C, Raimondo M, Di Perna M, Troncone G, Ciancia G, Intrieri M, Pane F.

Br J Haematol. 2018 Sep;182(5):715-718. doi: 10.1111/bjh.14856. Epub 2017 Jul 24. No abstract available.

PMID:
28737231
43.

Recommendations for screening, monitoring, prevention, prophylaxis and therapy of hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation-a position paper.

Sarmati L, Andreoni M, Antonelli G, Arcese W, Bruno R, Coppola N, Gaeta GB, Galli M, Girmenia C, Mikulska M, Pane F, Perno CF, Picardi M, Puoti M, Rambaldi A, Svicher V, Taliani G, Gentile G.

Clin Microbiol Infect. 2017 Dec;23(12):935-940. doi: 10.1016/j.cmi.2017.06.023. Epub 2017 Jun 29.

44.

Quantitative determination of free D-Asp, L-Asp and N-methyl-D-aspartate in mouse brain tissues by chiral separation and Multiple Reaction Monitoring tandem mass spectrometry.

Fontanarosa C, Pane F, Sepe N, Pinto G, Trifuoggi M, Squillace M, Errico F, Usiello A, Pucci P, Amoresano A.

PLoS One. 2017 Jun 29;12(6):e0179748. doi: 10.1371/journal.pone.0179748. eCollection 2017.

45.

Chronic myeloid leukemia: room for improvement?

Baccarani M, Pane F, Rosti G, Russo D, Saglio G.

Haematologica. 2017 Jul;102(7):1131-1133. doi: 10.3324/haematol.2017.166280. No abstract available.

46.

Incidence of second primary malignancies and related mortality in patients with imatinib-treated chronic myeloid leukemia.

Gugliotta G, Castagnetti F, Breccia M, Albano F, Iurlo A, Intermesoli T, Abruzzese E, Levato L, D'Adda M, Pregno P, Cavazzini F, Stagno F, Martino B, La Barba G, Sorà F, Tiribelli M, Bigazzi C, Binotto G, Bonifacio M, Caracciolo C, Soverini S, Foà R, Cavo M, Martinelli G, Pane F, Saglio G, Baccarani M, Rosti G; Gruppo Italiano Malattie Ematologiche dell’Adulto - Chronic Myeloid Leukemia Working Party.

Haematologica. 2017 Sep;102(9):1530-1536. doi: 10.3324/haematol.2017.169532. Epub 2017 Jun 1.

47.

Ultrasonography-driven combination antibiotic therapy with tigecycline significantly increases survival among patients with neutropenic enterocolitis following cytarabine-containing chemotherapy for the remission induction of acute myeloid leukemia.

Pugliese N, Salvatore P, Iula DV, Catania MR, Chiurazzi F, Della Pepa R, Cerchione C, Raimondo M, Giordano C, Simeone L, Caruso S, Pane F, Picardi M.

Cancer Med. 2017 Jul;6(7):1500-1511. doi: 10.1002/cam4.1063. Epub 2017 May 26.

48.

The BCR-ABL1 transcript type influences response and outcome in Philadelphia chromosome-positive chronic myeloid leukemia patients treated frontline with imatinib.

Castagnetti F, Gugliotta G, Breccia M, Iurlo A, Levato L, Albano F, Vigneri P, Abruzzese E, Rossi G, Rupoli S, Cavazzini F, Martino B, Orlandi E, Pregno P, Annunziata M, Usala E, Tiribelli M, Sica S, Bonifacio M, Fava C, Gherlinzoni F, Bocchia M, Soverini S, Bochicchio MT, Cavo M, Giovanni M, Saglio G, Pane F, Baccarani M, Rosti G; GIMEMA CML Working Party.

Am J Hematol. 2017 Aug;92(8):797-805. doi: 10.1002/ajh.24774. Epub 2017 May 30.

49.

Recommendations for molecular testing in classical Ph1-neg myeloproliferative disorders-A consensus project of the Italian Society of Hematology.

Guglielmelli P, Pietra D, Pane F, Pancrazzi A, Cazzola M, Vannucchi AM, Tura S, Barosi G.

Leuk Res. 2017 Jul;58:63-72. doi: 10.1016/j.leukres.2017.04.006. Epub 2017 Apr 23. Review.

PMID:
28460339
50.

Secondary syphilis mimicking malignancy: A case report and review of literature.

Cerchione C, Maraolo AE, Marano L, Pugliese N, Nappi D, Tosone G, Cimmino I, Cozzolino I, Martinelli V, Pane F, Picardi M.

J Infect Chemother. 2017 Aug;23(8):576-578. doi: 10.1016/j.jiac.2017.03.003. Epub 2017 Apr 26. Review.

PMID:
28456488

Supplemental Content

Support Center